Business Context and Reporting Period
This Form 6-K filing by Banco Bradesco S.A. (Bradesco) covers the month of March 2026, with the report dated March 6, 2026. The filing provides an update on the corporate reorganization to consolidate the healthcare businesses of the Bradesco Organization into Odontoprev S.A. (Odontoprev).
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on corporate governance and transactional updates regarding the healthcare business consolidation.
Material Changes and Transaction Updates
- First Amendment Execution: Management of Bradesco Gestão de Saúde S.A. (BGS), Odontoprev, Bradesco, and Bradseg Participações S.A. signed the First Amendment to the Protocol and Justification for the Merger of Shares.
- Valuation Adjustment: The amendment incorporates information from an appraisal report dated March 5, 2026, regarding the market value of BGS shares to determine the capital increase of Odontoprev.
- Shareholder Meeting Convened: An Extraordinary General Shareholders' Meeting (EGM) of Odontoprev has been scheduled to approve:
- The merger of BGS by Odontoprev and the amended protocol.
- The consequent capital increase of Odontoprev.
- Amendments to Odontoprev's Bylaws, including a name change to "Bradsaúde S.A."
- The Asset Contribution to Mediservice Operadora de Planos de Saúde S.A.
Guidance, Outlook, and Risks
Management states that the developments described follow what was originally contemplated and do not bring changes to the terms and conditions of the Transaction. The filing includes a standard forward-looking statements disclaimer, noting that future results depend on economic conditions, industry trends, and operating factors, and that actual results may differ materially from current expectations.
Investor Verification Checklist
- Verify the details of the Odontoprev Extraordinary General Shareholders' Meeting (EGM) via the convening notice on the Odontoprev Investor Relations website.
- Review the appraisal report dated March 5, 2026, for BGS shares to understand the valuation basis for the capital increase.
- Confirm the timeline for the name change of Odontoprev to "Bradsaúde S.A."
- Monitor subsequent filings for the final approval of the merger and asset contribution to Mediservice.